These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17116777)

  • 1. Viewpoint: The safety of drug-eluting stents.
    Shurlock B
    Circulation; 2006 Nov; 114(21):f181-3. PubMed ID: 17116777
    [No Abstract]   [Full Text] [Related]  

  • 2. TCT Daily: safety profile of drug-eluting stents similar to bare-metal stents: lower restenosis rates associated with DES.
    Kahn J
    J Interv Cardiol; 2007 Feb; 20(1):30-1. PubMed ID: 17300395
    [No Abstract]   [Full Text] [Related]  

  • 3. Concerns over safety of drug-eluting stents.
    Expert Rev Med Devices; 2006 Nov; 3(6):689-90. PubMed ID: 17280532
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.
    Pasceri V; Patti G; Speciale G; Pristipino C; Richichi G; Di Sciascio G
    Am Heart J; 2007 May; 153(5):749-54. PubMed ID: 17452148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents.
    Serruys PW; Daemen J
    Circulation; 2007 Mar; 115(11):1433-9; discussion 1439. PubMed ID: 17344323
    [No Abstract]   [Full Text] [Related]  

  • 6. Late thrombosis and drug-eluting stents.
    Williams D
    Med Device Technol; 2006; 17(9):8, 10. PubMed ID: 17240679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?
    Ryan J; Cohen DJ; Pinto DS
    Coron Artery Dis; 2006 Dec; 17(8):667-71. PubMed ID: 17119374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractured DES with a patent coronary artery: clinical implications.
    Park JS; Shin DG; Kim YJ
    J Invasive Cardiol; 2007 Feb; 19(2):E43-5. PubMed ID: 17268051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benefits and risks of drug-eluting stents].
    Zijlstra F
    Ned Tijdschr Geneeskd; 2007 May; 151(18):1005-7. PubMed ID: 17508683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents in primary angioplasty long-term clinical outcomes.
    Fiarresga AJ; Fernandes R; Feliciano J; de Sousa L; Cacela D; Bernardes L; Patrício L; Ferreira RC; Quininha J
    Rev Port Cardiol; 2007 Mar; 26(3):211-22. PubMed ID: 17549979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Are drug-eluting stents dangerous?].
    De Benedetti E; Urban P
    Rev Med Suisse; 2007 Mar; 3(102):656-8. PubMed ID: 17444198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCT Daily: new trials set to examine drug-eluting stents: doctors urged to weigh benefits, risks of drug-eluting stents on per patient basis.
    J Interv Cardiol; 2007 Feb; 20(1):33. PubMed ID: 17300397
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting stents "deliver heartburn": how do we spell relief going forward?
    Krucoff MW; Boam A; Schultz DG
    Circulation; 2007 Jun; 115(23):2990-4. PubMed ID: 17473280
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk profiling patients for selective use of drug-eluting stents is warranted.
    Farkouh ME; Bansilal S; Fuster V
    Nat Clin Pract Cardiovasc Med; 2007 Jul; 4(7):346-7. PubMed ID: 17519913
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing the landscape of stent thrombosis: the drug-eluting versus bare-metal stent controversy.
    Rizik DG; Klassen KJ
    Am J Cardiol; 2008 Nov; 102(9 Suppl):4J-11J. PubMed ID: 18928786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated coronary collateral function after drug-eluting stent implantation: a new downside of drug-eluting stents?
    Kern MJ
    J Am Coll Cardiol; 2007 Jan; 49(1):21-2. PubMed ID: 17207717
    [No Abstract]   [Full Text] [Related]  

  • 17. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
    Kedia G; Lee MS
    Catheter Cardiovasc Interv; 2007 May; 69(6):782-9. PubMed ID: 17394249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents will carry a warning.
    Expert Rev Med Devices; 2007 Jan; 4(1):9. PubMed ID: 17187475
    [No Abstract]   [Full Text] [Related]  

  • 19. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.
    Jensen LO; Maeng M; Kaltoft A; Thayssen P; Hansen HH; Bottcher M; Lassen JF; Krussel LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Soerensen HT; Thuesen L
    J Am Coll Cardiol; 2007 Jul; 50(5):463-70. PubMed ID: 17662400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-up.
    Sandhu G; Doyle B; Singh R; Bell M; Bresnahan J; Mathew V; Holmes D; Lerman A; Rihal C
    Am J Cardiol; 2007 Feb; 99(4):465-9. PubMed ID: 17293185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.